tradingkey.logo
tradingkey.logo
Search

Pro-Dex Inc

PDEX
Add to Watchlist
59.270USD
+0.620+1.06%
Close 05/15, 16:00ETQuotes delayed by 15 min
189.23MMarket Cap
15.99P/E TTM

Pro-Dex Inc

59.270
+0.620+1.06%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Pro-Dex Inc

Currency: USD Updated: 2026-05-15

Key Insights

Pro-Dex Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 128 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 70.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pro-Dex Inc's Score

Industry at a Glance

Industry Ranking
128 / 206
Overall Ranking
294 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Pro-Dex Inc Highlights

StrengthsRisks
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.49% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 66.59M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 66.59M.
Fairly Valued
The company’s latest PE is 15.99, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.14M shares, decreasing 13.23% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 1.65K shares of this stock.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
70.000
Target Price
+19.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Pro-Dex Inc is 8.95, ranking 10 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 19.95M, representing a year-over-year increase of 14.56%, while its net profit experienced a year-over-year increase of 20.24%.

Score

Industry at a Glance

Previous score
8.95
Change
0

Financials

9.40

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.85

Operational Efficiency

8.68

Growth Potential

10.00

Shareholder Returns

7.81

Pro-Dex Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Pro-Dex Inc is 6.77, ranking 147 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 15.99, which is 192.13% below the recent high of 46.70 and 55.82% above the recent low of 7.06.

Score

Industry at a Glance

Previous score
6.77
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 128/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for Pro-Dex Inc. The Healthcare Equipment & Supplies industry's average is 7.80. The average price target is 56.00, with a high of 56.00 and a low of 56.00.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
70.000
Target Price
+19.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

116
Total
6
Median
9
Average
Company name
Ratings
Analysts
Pro-Dex Inc
PDEX
1
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Pro-Dex Inc is 9.69, ranking 2 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 66.17 and the support level at 47.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.59
Change
0.1

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.868
Buy
RSI(14)
65.179
Neutral
STOCH(KDJ)(9,3,3)
77.887
Neutral
ATR(14)
3.190
High Vlolatility
CCI(14)
75.538
Neutral
Williams %R
12.807
Overbought
TRIX(12,20)
0.589
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
57.674
Buy
MA10
57.079
Buy
MA20
54.023
Buy
MA50
51.131
Buy
MA100
46.006
Buy
MA200
41.407
Buy

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Pro-Dex Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 35.84%, representing a quarter-over-quarter increase of 13.89%. The largest institutional shareholder is Invesco, holding a total of 1.65K shares, representing 0.05% of shares outstanding, with 32.06% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Swenson (Nicholas John)
1.02M
+0.10%
Farnam Street Capital, Inc.
270.85K
-3.20%
BlackRock Institutional Trust Company, N.A.
147.82K
+2.00%
Van Kirk (Richard Lee Jr)
98.71K
-0.07%
Punch & Associates Investment Management, Inc.
60.00K
+23.44%
Dimensional Fund Advisors, L.P.
62.12K
-0.65%
Geode Capital Management, L.L.C.
49.46K
-0.08%
Northern Trust Investments, Inc.
40.35K
-0.27%
J.P. Morgan Securities LLC
33.05K
-1.44%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Pro-Dex Inc is 2.81, ranking 142 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.08. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
2.81
Change
0
Beta vs S&P 500 index
-0.07
VaR
+5.16%
240-Day Maximum Drawdown
+55.32%
240-Day Volatility
+66.67%

Return

Best Daily Return
60 days
+9.31%
120 days
+10.34%
5 years
+22.96%
Worst Daily Return
60 days
-6.08%
120 days
-8.30%
5 years
-31.86%
Sharpe Ratio
60 days
+3.49
120 days
+3.17
5 years
+0.55

Risk Assessment

Maximum Drawdown
240 days
+55.32%
3 years
+65.36%
5 years
+65.36%
Return-to-Drawdown Ratio
240 days
+0.92
3 years
+1.17
5 years
+0.31
Skewness
240 days
-0.67
3 years
-0.42
5 years
-0.32

Volatility

Realised Volatility
240 days
+66.67%
5 years
+64.80%
Standardised True Range
240 days
+4.08%
5 years
+2.55%
Downside Risk-Adjusted Return
120 days
+522.23%
240 days
+522.23%
Maximum Daily Upside Volatility
60 days
+42.84%
Maximum Daily Downside Volatility
60 days
+40.54%

Liquidity

Average Turnover Rate
60 days
+0.80%
120 days
+0.84%
5 years
--
Turnover Deviation
20 days
-25.68%
60 days
-27.83%
120 days
-24.09%

Peer Comparison

Healthcare Equipment & Supplies
Pro-Dex Inc
Pro-Dex Inc
PDEX
5.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI